封面
市場調查報告書
商品編碼
1405846

原位雜合反應市場規模、佔有率、趨勢分析報告:按技術、按探針類型、按產品類型、按應用、按最終用途、按地區、細分市場預測,2024-2030 年

In Situ Hybridization Market Size, Share & Trends Analysis Report By Technology, By Probe Type, By Product, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

原位雜合反應市場成長與趨勢:

根據Grand View Research, Inc.最新報告,預計到2030年,全球原位雜合反應市場規模將達到25.5億美元,預測期內複合年成長率為7.2%。

原位雜合反應(ISH)廣泛應用於診斷研究和臨床應用。 ISH 是研究人員中流行的方法,因為它有助於確定特定核酸的分佈及其與目標基因蛋白產物的關係。因此,ISH的應用範圍正在加速擴大,引發進一步的研究。

隨著人們對 ISH 技術及其用途的認知不斷提高,研究人員正在將其用於各種應用。例如,MultiplexDX的執行長在接受Elsevier採訪時表示,FISH技術可以為早期藥物開發和個體化治療貢獻突破性資訊。已開發國家意識的提高意味著更多的人選擇個體化治療,從而推動市場需求。

此外,新興經濟體保險報銷系統的可用性正在增加對此診斷的需求。隨著最近保險覆蓋率的擴大,大多數人現在可以獲得治療,並且需求持續增加。例如,在美國,醫療保險是最大的市場參與者,為 65 歲及以上的老年人提供護理,無論收入或病歷如何。

由於COVID-19大流行,需求方對ISH市場產生了積極影響,因為各種研究人員在COVID-19感染細胞上採用了ISH技術。 2020 年 7 月發表的一項研究使用 ISH 測定和 RNA 探針檢查了來自 COVID-19 感染患者的 8 個屍檢肺、10 個切片檢查和 1 個胎盤。

ISH 在所有八個肺部和胎盤中均顯示出陽性 COVID-19 結果,但在腎臟樣本中未顯示陽性結果。該測定代表了一種用於檢測組織樣本中病毒的靈敏且特異性的技術。同樣,Advanced Cell Diagnostics, Inc. 推出了 RNAscope 技術來支援 COVID-19 研究。

公司不斷採取的策略性舉措預計將推動 ISH 市場的成長。主要企業正在向市場推出新產品以增強其產品組合。例如,2021年3月,F. Hoffmann-La Roche推出了DISCOVERY Green HRP顯色檢測套件,擴展了原位雜合反應和免疫組化的多重檢測能力。

另一方面,分子診斷提供準確有效的結果,是診斷領域的重要應用。然而,FISH 檢測的高製造成本以及維護用於 FISH 成像的專業組裝廠和設備所需的高資本可能會限制產生收入。

原位雜合反應市場報告亮點

  • 從技術面來看,CISH 產業預計在預測期內將以最快的成長率擴張。 CISH使用的試劑更加穩定,因此樣本可以保存更長時間並進行多次測試。
  • 根據探針,DNA 片段預計將在預測期內表現出最快的成長率。這是因為與染色體異常相關的疾病(例如遺傳異常和癌症)的發生率正在增加。
  • 按產品分類,2024年至2030年服務業預計將以最快的複合年成長率成長。增加外包以確保品質標準和改善業務功能有助於實現良好的成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章市場變數、趨勢和範圍

  • 市場區隔和範圍
  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場趨勢及展望
  • 市場動態
    • 目標疾病盛行率上升
    • 體外診斷領域的技術進展
    • 加大體外診斷研發投入
  • 市場抑制因素分析
    • ISH費用高
    • 法規結構不明確
  • 2023 年普及與成長前景圖
  • 營商環境分析
    • SWOT 分析;按因素(政治/法律、經濟/技術)
    • 波特五力分析

第4章科技業務分析

  • 原位雜合反應市場:產品類型變異分析
  • FISH
    • 魚類市場,2018-2030
  • CISH
    • CISH 市場,2018-2030

第5章 探索業務分析

  • 原位雜合反應市場:位點變異分析
  • DNA
    • DNA 市場,2018-2030
  • RNA
    • RNA市場,2018-2030

第6章 產品經營分析

  • 原位雜合反應市場:位點變異分析
  • 裝置
    • 2018-2030年設備市場
  • 耗材及配件
    • 消耗品及配件市場,2018-2030
  • 軟體
    • 軟體市場,2018-2030
  • 服務
    • 服務市場,2018-2030

第7章 應用業務分析

  • 原位雜合反應市場:產品類型變異分析
  • 癌症
    • 癌症市場,2018-2030
  • 細胞遺傳學
    • 細胞遺傳學市場,2018-2030
  • 發育生物學
    • 發育生物學市場,2018-2030
  • 感染疾病
    • 感染疾病市場,2018-2030
  • 其他
    • 其他市場,2018-2030

第 8 章最終用途業務分析

  • 原位雜合反應市場:最終用途變化分析
  • 醫院和診斷實驗室
    • 醫院和診斷實驗室市場,2018-2030
  • CRO
    • CRO市場,2018-2030
  • 學術/研究機構
    • 學術和研究機構市場,2018-2030
  • 其他
    • 其他市場,2018-2030

第9章區域業務分析

  • 2023 年及 2030 年原位雜合反應市場佔有率(按地區)
  • 北美洲
    • SWOT分析
    • 北美原位雜合反應市場,2018-2030
    • 美國
    • 加拿大
  • 歐洲
    • SWOT分析
    • 歐洲原位雜合反應市場,2018-2030
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • SWOT分析
    • 亞太原位雜合反應市場,2018-2030
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • SWOT分析
    • 拉丁美洲原位雜合反應市場,2018-2030
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • SWOT分析
    • 中東和非洲原位雜合反應市場,2018-2030
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第10章競爭形勢

  • 公司分類
  • 策略規劃
    • 新產品發布
    • 合夥
    • 獲得
    • 合作
    • 資金籌措
  • 2023年主要企業市場佔有率分析
  • 企業熱力圖分析
  • 公司簡介
    • PerkinElmer, Inc.
    • Thermo Fisher Scientific, Inc.
    • BioView
    • Agilent Technologies, Inc.
    • Merck KGaA
    • Bio-Rad Laboratories, Inc.
    • OXFORD GENE TECHNOLOGY IP LIMITED
    • LEICA BIOSYSTEMS NUSSLOCH GMBH(DANAHER CORPORATION)
    • NEOGENOMICS LABORATORIES, INC.
    • ADVANCED CELL DIAGNOSTICS, INC.
Product Code: GVR-2-68038-109-2

In Situ Hybridization Market Growth & Trends:

The global in situ hybridization market size is expected to reach USD 2.55 billion by 2030, registering a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Situ Hybridization (ISH) is extensively utilized for research and clinical applications of diagnostics. ISH is a popular approach among researchers as it aids in determining the relationship between the distribution of specific nucleic acids and the target gene protein products. Hence, expanding the scope of ISH in applications is accelerating and leading to further research.

The increasing awareness about ISH techniques and their usage encourages researchers to employ the techniques for various applications. For instance, the CEO of MultiplexDX stated in an interview with Elsevier that FISH technology can contribute breakthrough information for early drug development and personalized treatment. A growing number of people in developed countries are opting for personalized treatment owing to an increase in awareness, thus boosting market demand.

Furthermore, reimbursement schemes being made available in developed economies have led to an increase in demand for this diagnosis. The demand continues to increase as the majority of the public can now afford it due to the recent expansion through insurance coverage. For instance, Medicare is the largest market player in the U.S., which provides care for those aged 65 years and above, irrespective of their income and medical history.

Owing to the COVID-19 pandemic, the demand side showcased a positive impact on the ISH market as various researchers employed the technique on COVID-19-infected cells. Research published in July 2020, considered 8 autopsy lungs, 10 kidney biopsies, and 1 placenta from COVID-19-infected patients with ISH assay and RNA probes.

COVID-19 positive results showed in all 8 lungs and the placenta by ISH, but not in the kidney samples. The assay showcases a sensitive and specific technique for detecting the virus from tissue samples. Similarly, Advanced Cell Diagnostics, Inc., introduced RNAscope technology to support COVID-19 research.

The growing strategic initiatives by the companies are anticipated to boost the ISH market growth. Key players are introducing novel products in the market to strengthen their portfolios. For instance, in March 2021, F. Hoffmann-La Roche launched DISCOVERY Green HRP chromogen detection kit to expand the multiplexing capability of in situ hybridization and immunohistochemistry.

On the other hand, molecular diagnostics renders accurate & effective results and has indispensable applications in the field of diagnosis. However, the high manufacturing cost of FISH assays and the high amount of capital required for specialized assembly plants & maintenance of instruments used in FISH imaging are likely to limit revenue generation.

In Situ Hybridization Market Report Highlights:

  • By technology, the CISH segment is projected to expand at the fastest growth rate during the forecast period. Since the reagents used in CISH are more stable, the sample can be stored for a longer duration and can be examined multiple times
  • By probe, the DNA segment is anticipated to have the fastest growth rate during the forecast period. Owing to the increasing incidence of diseases associated with chromosomal aberrations, such as genetic abnormalities and cancer
  • By product, the services segment is anticipated to have the fastest-growing CAGR between 2024 to 2030. Increasing outsourcing to ensure high adherence to quality standards and improve operational functionalities contributes to the lucrative growth.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation
    • 1.1.1. Market Definitions
  • 1.2. Objectives
    • 1.2.1. Objective - 1
    • 1.2.2. Objective - 2
    • 1.2.3. Objective - 3
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Abbreviations
  • 1.10. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Segmentation and Scope
  • 3.2. Market Lineage Outlook
    • 3.2.1. Parent Market Outlook
    • 3.2.2. Related/Ancillary Market Outlook
  • 3.3. Market Trends and Outlook
  • 3.4. Market Dynamics
    • 3.4.1. Rising Prevalence of Target Disorders
    • 3.4.2. Technological Advancement In the Field of In Vitro Diagnostics
    • 3.4.3. Increasing R&D Investments In In Vitro Diagnostics
  • 3.5. Market Restraint Analysis
    • 3.5.1. High Cost of ISH
    • 3.5.2. Presence of An Ambiguous Regulatory Framework
  • 3.6. Penetration and Growth Prospect Mapping 2023
  • 3.7. Business Environment Analysis
    • 3.7.1. SWOT Analysis; By Factor (Political & Legal, Economic And Technological)
    • 3.7.2. Porter's Five Forces Analysis

Chapter 4. Technology Business Analysis

  • 4.1. In Situ Hybridization Market: Product Type Movement Analysis
  • 4.2. FISH
    • 4.2.1. FISH Market, 2018 - 2030 (USD Million)
  • 4.3. CISH
    • 4.3.1. CISH Market, 2018 - 2030 (USD Million)

Chapter 5. Probe Business Analysis

  • 5.1. In Situ Hybridization Market: Site Movement Analysis
  • 5.2. DNA
    • 5.2.1. DNA Market, 2018 - 2030 (USD Million)
  • 5.3. RNA
    • 5.3.1. RNA Market, 2018 - 2030 (USD Million)

Chapter 6. Product Business Analysis

  • 6.1. In Situ Hybridization Market: Site Movement Analysis
  • 6.2. Instruments
    • 6.2.1. Instruments Market, 2018 - 2030 (USD Million)
  • 6.3. Consumables & Accessories
    • 6.3.1. Consumables & Accessories Market, 2018 - 2030 (USD Million)
  • 6.4. Software
    • 6.4.1. Software Market, 2018 - 2030 (USD Million)
  • 6.5. Services
    • 6.5.1. Services Market, 2018 - 2030 (USD Million)

Chapter 7. Application Business Analysis

  • 7.1. In Situ Hybridization Market: Product Type Movement Analysis
  • 7.2. Cancer
    • 7.2.1. Cancer Market, 2018 - 2030 (USD Million)
  • 7.3. Cytogenetics
    • 7.3.1. Cytogenetics Market, 2018 - 2030 (USD Million)
  • 7.4. Developmental Biology
    • 7.4.1. Developmental Biology Market, 2018 - 2030 (USD Million)
  • 7.5. Infectious Diseases
    • 7.5.1. Infectious Diseases Market, 2018 - 2030 (USD Million)
  • 7.6. Others
    • 7.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. End-use Business Analysis

  • 8.1. In Situ Hybridization Market: End-use Movement Analysis
  • 8.2. Hospitals & Diagnostic Laboratories
    • 8.2.1. Hospitals & Diagnostic Laboratories Market, 2018 - 2030 (USD Million)
  • 8.3. CROs
    • 8.3.1. CROs Market, 2018 - 2030 (USD Million)
  • 8.4. Academic & Research Institutes
    • 8.4.1. Academic & Research Institutes Market, 2018 - 2030 (USD Million)
  • 8.5. Others
    • 8.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 9. Regional Business Analysis

  • 9.1. In Situ Hybridization Market Share By Region, 2023 & 2030
  • 9.2. North America
    • 9.2.1. SWOT Analysis
    • 9.2.2. North America In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.2.3. U.S.
      • 9.2.3.1. Key Country Dynamics
      • 9.2.3.2. Target Disease Scenario
      • 9.2.3.3. Competitive Scenario
      • 9.2.3.4. Regulatory Framework
      • 9.2.3.5. Reimbursement Scenario
      • 9.2.3.6. U.S. In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.2.4. Canada
      • 9.2.4.1. Key Country Dynamics
      • 9.2.4.2. Target Disease Scenario
      • 9.2.4.3. Competitive Scenario
      • 9.2.4.4. Regulatory Framework
      • 9.2.4.5. Reimbursement Scenario
      • 9.2.4.6. Canada In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.3. Europe
    • 9.3.1. SWOT Analysis
    • 9.3.2. Europe In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.3. Germany
      • 9.3.3.1. Key Country Dynamics
      • 9.3.3.2. Target Disease Scenario
      • 9.3.3.3. Competitive Scenario
      • 9.3.3.4. Regulatory Framework
      • 9.3.3.5. Reimbursement Scenario
      • 9.3.3.6. Germany In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.4. UK
      • 9.3.4.1. Key Country Dynamics
      • 9.3.4.2. Target Disease Scenario
      • 9.3.4.3. Competitive Scenario
      • 9.3.4.4. Regulatory Framework
      • 9.3.4.5. Reimbursement Scenario
      • 9.3.4.6. UK In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.5. France
      • 9.3.5.1. Key Country Dynamics
      • 9.3.5.2. Target Disease Scenario
      • 9.3.5.3. Competitive Scenario
      • 9.3.5.4. Regulatory Framework
      • 9.3.5.5. Reimbursement Scenario
      • 9.3.5.6. France In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.6. Italy
      • 9.3.6.1. Key Country Dynamics
      • 9.3.6.2. Target Disease Scenario
      • 9.3.6.3. Competitive Scenario
      • 9.3.6.4. Regulatory Framework
      • 9.3.6.5. Reimbursement Scenario
      • 9.3.6.6. Italy In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.7. Spain
      • 9.3.7.1. Key Country Dynamics
      • 9.3.7.2. Target Disease Scenario
      • 9.3.7.3. Competitive Scenario
      • 9.3.7.4. Regulatory Framework
      • 9.3.7.5. Reimbursement Scenario
      • 9.3.7.6. Spain In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.8. Denmark
      • 9.3.8.1. Key Country Dynamics
      • 9.3.8.2. Target Disease Scenario
      • 9.3.8.3. Competitive Scenario
      • 9.3.8.4. Regulatory Framework
      • 9.3.8.5. Reimbursement Scenario
      • 9.3.8.6. Denmark In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.9. Sweden
      • 9.3.9.1. Key Country Dynamics
      • 9.3.9.2. Target Disease Scenario
      • 9.3.9.3. Competitive Scenario
      • 9.3.9.4. Regulatory Framework
      • 9.3.9.5. Reimbursement Scenario
      • 9.3.9.6. Sweden In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.3.10. Norway
      • 9.3.10.1. Key Country Dynamics
      • 9.3.10.2. Target Disease Scenario
      • 9.3.10.3. Competitive Scenario
      • 9.3.10.4. Regulatory Framework
      • 9.3.10.5. Reimbursement Scenario
      • 9.3.10.6. Norway In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.4. Asia Pacific
    • 9.4.1. SWOT Analysis
    • 9.4.2. Asia Pacific In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.3. Japan
      • 9.4.3.1. Key Country Dynamics
      • 9.4.3.2. Target Disease Scenario
      • 9.4.3.3. Competitive Scenario
      • 9.4.3.4. Regulatory Framework
      • 9.4.3.5. Reimbursement Scenario
      • 9.4.3.6. Japan In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.4. China
      • 9.4.4.1. Key Country Dynamics
      • 9.4.4.2. Target Disease Scenario
      • 9.4.4.3. Competitive Scenario
      • 9.4.4.4. Regulatory Framework
      • 9.4.4.5. Reimbursement Scenario
      • 9.4.4.6. China In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.5. India
      • 9.4.5.1. Key Country Dynamics
      • 9.4.5.2. Target Disease Scenario
      • 9.4.5.3. Competitive Scenario
      • 9.4.5.4. Regulatory Framework
      • 9.4.5.5. Reimbursement Scenario
      • 9.4.5.6. India In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.6. South Korea
      • 9.4.6.1. Key Country Dynamics
      • 9.4.6.2. Target Disease Scenario
      • 9.4.6.3. Competitive Scenario
      • 9.4.6.4. Regulatory Framework
      • 9.4.6.5. Reimbursement Scenario
      • 9.4.6.6. South Korea In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.7. Australia
      • 9.4.7.1. Key Country Dynamics
      • 9.4.7.2. Target Disease Scenario
      • 9.4.7.3. Competitive Scenario
      • 9.4.7.4. Regulatory Framework
      • 9.4.7.5. Reimbursement Scenario
      • 9.4.7.6. Australia In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.4.8. Thailand
      • 9.4.8.1. Key Country Dynamics
      • 9.4.8.2. Target Disease Scenario
      • 9.4.8.3. Competitive Scenario
      • 9.4.8.4. Regulatory Framework
      • 9.4.8.5. Reimbursement Scenario
      • 9.4.8.6. Thailand In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.5. Latin America
    • 9.5.1. SWOT Analysis
    • 9.5.2. Latin America In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.5.3. Brazil
      • 9.5.3.1. Key Country Dynamics
      • 9.5.3.2. Target Disease Scenario
      • 9.5.3.3. Competitive Scenario
      • 9.5.3.4. Regulatory Framework
      • 9.5.3.5. Reimbursement Scenario
      • 9.5.3.6. Brazil In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.5.4. Mexico
      • 9.5.4.1. Key Country Dynamics
      • 9.5.4.2. Target Disease Scenario
      • 9.5.4.3. Competitive Scenario
      • 9.5.4.4. Regulatory Framework
      • 9.5.4.5. Reimbursement Scenario
      • 9.5.4.6. Mexico In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.5.5. Argentina
      • 9.5.5.1. Key Country Dynamics
      • 9.5.5.2. Target Disease Scenario
      • 9.5.5.3. Competitive Scenario
      • 9.5.5.4. Regulatory Framework
      • 9.5.5.5. Reimbursement Scenario
      • 9.5.5.6. Argentina In Situ Hybridization Market, 2018 - 2030 (USD Million)
  • 9.6. MEA
    • 9.6.1. SWOT Analysis
    • 9.6.2. MEA In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.3. South Africa
      • 9.6.3.1. Key Country Dynamics
      • 9.6.3.2. Target Disease Scenario
      • 9.6.3.3. Competitive Scenario
      • 9.6.3.4. Regulatory Framework
      • 9.6.3.5. Reimbursement Scenario
      • 9.6.3.6. South Africa In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.4. Saudi Arabia
      • 9.6.4.1. Key Country Dynamics
      • 9.6.4.2. Target Disease Scenario
      • 9.6.4.3. Competitive Scenario
      • 9.6.4.4. Regulatory Framework
      • 9.6.4.5. Reimbursement Scenario
      • 9.6.4.6. Saudi Arabia In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.5. UAE
      • 9.6.5.1. Key Country Dynamics
      • 9.6.5.2. Target Disease Scenario
      • 9.6.5.3. Competitive Scenario
      • 9.6.5.4. Regulatory Framework
      • 9.6.5.5. Reimbursement Scenario
      • 9.6.5.6. UAE In Situ Hybridization Market, 2018 - 2030 (USD Million)
    • 9.6.6. Kuwait
      • 9.6.6.1. Key Country Dynamics
      • 9.6.6.2. Target Disease Scenario
      • 9.6.6.3. Competitive Scenario
      • 9.6.6.4. Regulatory Framework
      • 9.6.6.5. Reimbursement Scenario
      • 9.6.6.6. Kuwait In Situ Hybridization Market, 2018 - 2030 (USD Million)

Chapter 10. Competitive Landscape

  • 10.1. Company Categorization
  • 10.2. Strategy Mapping
    • 10.2.1. New Product Launch
    • 10.2.2. Partnerships
    • 10.2.3. Acquisition
    • 10.2.4. Collaboration
    • 10.2.5. Funding
  • 10.3. Key Company Market Share Analysis, 2023
  • 10.4. Company Heat Map Analysis
  • 10.5. Company Profiles
    • 10.5.1. . PerkinElmer, Inc.
      • 10.5.1.1. Company Overview
      • 10.5.1.2. Financial Performance
      • 10.5.1.3. Product Benchmarking
      • 10.5.1.4. Strategic Initiatives
    • 10.5.2. Thermo Fisher Scientific, Inc.
      • 10.5.2.1. Company Overview
      • 10.5.2.2. Financial Performance
      • 10.5.2.3. Product Benchmarking
      • 10.5.2.4. Strategic Initiatives
    • 10.5.3. BioView
      • 10.5.3.1. Company Overview
      • 10.5.3.2. Financial Performance
      • 10.5.3.3. Product Benchmarking
      • 10.5.3.4. Strategic Initiatives
    • 10.5.4. Agilent Technologies, Inc.
      • 10.5.4.1. Company Overview
      • 10.5.4.2. Financial Performance
      • 10.5.4.3. Product Benchmarking
      • 10.5.4.4. Strategic Initiatives
    • 10.5.5. Merck KGaA
      • 10.5.5.1. Company Overview
      • 10.5.5.2. Financial Performance
      • 10.5.5.3. Product Benchmarking
      • 10.5.5.4. Strategic Initiatives
    • 10.5.6. Bio-Rad Laboratories, Inc.
      • 10.5.6.1. Company Overview
      • 10.5.6.2. Financial Performance
      • 10.5.6.3. Product Benchmarking
      • 10.5.6.4. Strategic Initiatives
    • 10.5.7. OXFORD GENE TECHNOLOGY IP LIMITED
      • 10.5.7.1. Financial Performance
      • 10.5.7.2. Product Benchmarking
      • 10.5.7.3. Strategic Initiatives
    • 10.5.8. LEICA BIOSYSTEMS NUSSLOCH GMBH (DANAHER CORPORATION)
      • 10.5.8.1. Company Overview
      • 10.5.8.2. Financial Performance
      • 10.5.8.3. Product Benchmarking
      • 10.5.8.4. Strategic Initiatives
    • 10.5.9. NEOGENOMICS LABORATORIES, INC.
      • 10.5.9.1. Financial Performance
      • 10.5.9.2. Product Benchmarking
      • 10.5.9.3. Strategic Initiatives
    • 10.5.10. ADVANCED CELL DIAGNOSTICS, INC.
      • 10.5.10.1. Company Overview
      • 10.5.10.2. Financial Performance
      • 10.5.10.3. Product Benchmarking
      • 10.5.10.4. Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 4 Global In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 5 Global In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 6 Global In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 7 Global In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 8 Global In Situ Hybridization Market, by Region, 2018 - 2030 (USD Million)
  • Table 9 North America In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 10 North America In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 11 North America In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 12 North America In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 13 North America In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 14 North America In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 15 U.S. In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 16 U.S. In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 17 U.S. In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 18 U.S. In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 19 U.S. In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 20 Canada In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 21 Canada In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 22 Canada In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 23 Canada In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 24 Canada In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 25 Europe In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 26 Europe In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 27 Europe In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 28 Europe In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 29 Europe In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 30 Europe In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 31 Germany In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 32 Germany In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 Germany In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 34 Germany In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 35 Germany In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 36 UK In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 37 UK In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 38 UK In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 39 UK In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 40 UK In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 41 France In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 42 France In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 43 France In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 44 France In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 45 France In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 46 Italy In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 47 Italy In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 48 Italy In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 49 Italy In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Italy In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 51 Spain In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 52 Spain In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 53 Spain In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 54 Spain In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 55 Spain In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 56 Sweden In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 57 Sweden In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 58 Sweden In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 59 Sweden In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 60 Sweden In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 61 Denmark In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 62 Denmark In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 63 Denmark In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 64 Denmark In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 65 Denmark In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 66 Norway In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 67 Norway In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 68 Norway In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 69 Norway In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Norway In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 71 Asia Pacific In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Asia Pacific In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 73 Asia Pacific In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 74 Asia Pacific In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 75 Asia Pacific In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 76 Asia Pacific In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 77 China In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 78 China In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 79 China In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 80 China In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 81 China In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 82 Japan In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Japan In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 84 Japan In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 85 Japan In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 86 Japan In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 87 India In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 88 India In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 89 Indian Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 90 India In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 91 Indian Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 92 South Korea In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 93 South Korea In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 94 South Korean Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 95 South Korea In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Korean Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 97 Australia In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 98 Australia In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 99 Australia In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 100 Australia In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 101 Australia In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 102 Thailand In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 103 Thailand In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 104 Thailand In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 105 Thailand In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 106 Thailand In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 107 Latin America In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 108 Latin America In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 109 Latin America In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 110 Latin America In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 111 Latin America In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 112 Latin America In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 113 Brazil In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 114 Brazil In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 115 Brazil in Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 116 Brazil In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 117 Brazil In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 118 Mexico In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 119 Mexico In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 120 Mexico In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 121 Mexico In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 122 Mexico In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 123 Argentina In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 124 Argentina In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 125 Argentina In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 126 Argentina In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 127 Argentina In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 128 Middle East & Africa In Situ Hybridization Market, by Country, 2018 - 2030 (USD Million)
  • Table 129 Middle East & Africa In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 130 Middle East & Africa In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 131 Middle East & Africa In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 132 Middle East & Africa In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 133 Middle East & Africa In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 134 South Africa In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 135 South Africa In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 136 South Africa In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 137 South Africa In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 138 South Africa In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 139 Saudi Arabia In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 140 Saudi Arabia In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 141 Saudi Arabia In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 142 Saudi Arabia In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 143 Saudi Arabia In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 144 UAE In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 145 UAE In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 146 UAE In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 147 UAE In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 148 UAE In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million)
  • Table 149 Kuwait In Situ Hybridization Market, by Technology, 2018 - 2030 (USD Million)
  • Table 150 Kuwait In Situ Hybridization Market, by Probe Type, 2018 - 2030 (USD Million)
  • Table 151 Kuwait In Situ Hybridization Market, by Product, 2018 - 2030 (USD Million)
  • Table 152 Kuwait In Situ Hybridization Market, by Application, 2018 - 2030 (USD Million)
  • Table 153 Kuwait In Situ Hybridization Market, by End Use, 2018 - 2030 (USD Million) 

List of Figures

  • Fig. 1 In situ hybridization market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation and validation
  • Fig. 9 Commodity flow approach
  • Fig. 10 Market snapshot (USD Million)
  • Fig. 11 Segment snapshot (technology, probe & end-use)
  • Fig. 12 Segment snapshot (product & application)
  • Fig. 13 Competitive snapshot
  • Fig. 14 Market trends & outlook
  • Fig. 15 Estimated number of new cases from 2020 to 2040, both sexes, age [0-85+], globally.
  • Fig. 16 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 17 Porter's five forces analysis
  • Fig. 18 In situ hybridization market: Technology type outlook key takeaways (USD Million)
  • Fig. 19 In situ hybridization market: Technology type movement analysis
  • Fig. 20 In situ hybridization market for FISH, 2018 - 2030 (USD Million)
  • Fig. 21 In situ hybridization market for CISH, 2018 - 2030 (USD Million)
  • Fig. 22 In situ hybridization market: Probe outlook key takeaways (USD Million)
  • Fig. 23 In situ hybridization market: Probe movement analysis
  • Fig. 24 In situ hybridization market for DNA, 2018 - 2030 (USD Million)
  • Fig. 25 In situ hybridization market for RNA, 2018 - 2030 (USD Million)
  • Fig. 26 In situ hybridization market: End-use outlook key takeaways (USD Million)
  • Fig. 27 In situ hybridization market: End-use type movement analysis
  • Fig. 28 In situ hybridization market for hospital & diagnostics laboratories, 2018 - 2030 (USD Million)
  • Fig. 29 In situ hybridization market for CROs, 2018 - 2030 (USD Million)
  • Fig. 30 In situ hybridization market for academic institutes, 2018 - 2030 (USD Million)
  • Fig. 31 In situ hybridization market for other end-use, 2018 - 2030 (USD Million)
  • Fig. 32 In situ hybridization market: Product outlook and key takeaways
  • Fig. 33 In situ hybridization market: Product movement analysis
  • Fig. 34 In situ hybridization market instruments, 2018 - 2030 (USD Million)
  • Fig. 35 In situ hybridization kits and probes market, 2018 - 2030 (USD Million)
  • Fig. 36 In situ hybridization software market, 2018 - 2030 (USD Million)
  • Fig. 37 In situ hybridization services market, 2018 - 2030 (USD Million)
  • Fig. 38 In situ hybridization market: Application outlook and key takeaways
  • Fig. 39 In situ hybridization market: Application movement analysis
  • Fig. 40 Cancer application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 41 Cytogenetics application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 42 Development biology application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 43 Infectious diseases application for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 44 Other applications for in situ hybridization market, 2018 - 2030 (USD Million)
  • Fig. 45 In situ hybridization market revenue, by region, 2022 & 2030 (USD Million)
  • Fig. 46 Regional marketplace: Key takeaways
  • Fig. 47 North America in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Key country dynamics
  • Fig. 49 U.S. in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Cancer Incidence, 2018 - 2030
  • Fig. 51 Competitive scenario
  • Fig. 52 Key country dynamics
  • Fig. 53 Canada in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Cancer incidence, 2018 - 2030
  • Fig. 55 Competitive scenario
  • Fig. 56 Europe in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Key country dynamics
  • Fig. 58 UK in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Cancer incidence, 2018 - 2030
  • Fig. 60 Competitive scenario
  • Fig. 61 Key country dynamics
  • Fig. 62 Germany in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Cancer incidence, 2018 - 2030
  • Fig. 64 Competitive scenario
  • Fig. 65 Key country dynamics
  • Fig. 66 France in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Cancer incidence, 2018 - 2030
  • Fig. 68 Competitive scenario
  • Fig. 69 Key country dynamics
  • Fig. 70 Spain in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Cancer incidence, 2018 - 2030
  • Fig. 72 Competitive scenario
  • Fig. 73 Key country dynamics
  • Fig. 74 Italy in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 75 Cancer incidence, 2018 - 2030
  • Fig. 76 Competitive scenario
  • Fig. 77 Key country dynamics
  • Fig. 78 Denmark in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 79 Target disease prevalence
  • Fig. 80 Competitive scenario
  • Fig. 81 Regulatory framework
  • Fig. 82 Key country dynamics
  • Fig. 83 Sweden in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 84 Five most common cancers in Sweden
  • Fig. 85 Competitive scenario
  • Fig. 86 Regulatory framework
  • Fig. 87 Key country dynamics
  • Fig. 88 Norway in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Number of new cancer cases in 2020, both sexes, all ages
  • Fig. 90 Competitive scenario
  • Fig. 91 Rest of Europe market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 Japan in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Cancer incidence, 2018 to 2030
  • Fig. 96 Competitive scenario
  • Fig. 97 Key country dynamics
  • Fig. 98 China in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Cancer incidence, 2018 to 2030
  • Fig. 100 Competitive scenario
  • Fig. 101 Key country dynamics
  • Fig. 102 India in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Cancer incidence, 2018 to 2030
  • Fig. 104 Competitive scenario
  • Fig. 105 Key country dynamics
  • Fig. 106 Australia in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Cancer incidence, 2018 to 2030
  • Fig. 108 Competitive scenario
  • Fig. 109 Key country dynamics
  • Fig. 110 Thailand in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Cancer incidence, 2020 to 2030
  • Fig. 112 Competitive scenario
  • Fig. 113 Key country dynamics
  • Fig. 114 South Korea in situ hybridization market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Cancer incidence 2018 to 2030
  • Fig. 116 Competitive scenario
  • Fig. 117 Rest of Asia Pacific market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 118 Latin America in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 119 Key country dynamics
  • Fig. 120 Brazil in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 121 Estimated number of new cancer cases in Brazil
  • Fig. 122 Competitive scenario
  • Fig. 123 Key country dynamics
  • Fig. 124 Mexico in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 125 Estimated number of new cancer cases in Mexico
  • Fig. 126 Competitive scenario
  • Fig. 127 Key country dynamics
  • Fig. 128 Argentina in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 129 Estimated number of new cancer cases in Argentina
  • Fig. 130 Competitive scenario
  • Fig. 131 Rest of LATAM market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 MEA in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 133 Key country dynamics
  • Fig. 134 South Africa in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 135 Cancer prevalence-2018 - 2030
  • Fig. 136 Competitive scenario
  • Fig. 137 Key country dynamics
  • Fig. 138 Saudi Arabia in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 139 Cancer prevalence-2018 - 2030
  • Fig. 140 Competitive scenario
  • Fig. 141 Key country dynamics
  • Fig. 142 UAE in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 143 Cancer prevalence 2018 - 2030
  • Fig. 144 Competitive scenario
  • Fig. 145 Key country dynamics
  • Fig. 146 Kuwait in situ hybridization market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 147 Target disease prevalence
  • Fig. 148 Competitive scenario
  • Fig. 149 Key payors in Kuwait
  • Fig. 150 Rest of MEA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Market participant categorization
  • Fig. 152 In situ hybridization market share analysis, 2022
  • Fig. 153 Strategic framework
  • Fig. 154 Ansoff Matrix
  • Fig. 155 Competition categorization
  • Fig. 156 Company market position analysis (Diagnostics)
  • Fig. 157 Company market position analysis